ArticleJournal of inflammation (London, England)2026
Montelukast suppresses NLRP3 inflammasome activation as a potential prophylactic agent against gout arthritis flares.
Daniel C Shippy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.